Presenting PRO results from comparative research studies in clinical practice to inform treatment decision-making: making pictures speak more clearly to patients and clinicians

被引：0
|
作者：
Brundage, Michael [1 ]
Bantug, Elissa [2 ]
Tolbert, Elliott [3 ]
Smith, Katherine C. [2 ]
Snyder, Claire [4 ]
机构：
[1] Queens Univ, Kingston Gen Hosp, Kingston, ON, Canada
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] Johns Hopkins Sch Med, Baltimore, MD USA
[4] Johns Hopkins Sch Med, Div Gen Internal Med, Baltimore, MD USA
来源：
QUALITY OF LIFE RESEARCH | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
3042
引用
收藏
页码：182 / 182
页数：1
相关论文
共 43 条
  • [31] A Genomic Classifier Impacts Treatment Decision Making Among Patients With Biochemical Recurrence After Radical Prostatectomy: Results From the Multicenter Prospective PRO-IMPACT Study
    Perrapato, S. D.
    Gore, J.
    du Plessis, M.
    Santiago-Jimenez, M.
    Yousefi, K.
    Thompson, D.
    Chen, D.
    Clark, W.
    Franks, M.
    Karsh, L.
    Kibel, A.
    Lane, B.
    Lotan, Y.
    Lowrance, W.
    Maroni, P.
    Trabulsi, E.
    Waterhouse, R.
    Davicioni, E.
    Lin, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E222 - E223
  • [32] Effect of decipher test on adjuvant treatment decision-making among men with high-risk pathology at radical prostatectomy: Results from a multicenter prospective PRO-IMPACT study.
    Gore, John L.
    du Plessis, Marguerite
    Santiago-Jimenez, Maria
    Yousefi, Kasra
    Thompson, Darby
    Chen, David
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [33] Effect of a genomic classifier on treatment decision making among patients with biochemical recurrence after radical prostatectomy: Results from the multicenter prospective PRO-IMPACT study.
    Gore, John L.
    Du Plessis, Marguerite
    Santiago-Jimenez, Maria
    Yousefi, Kasra
    Thompson, Darby J. S.
    Chen, David Y. T.
    Clark, William R.
    Franks, Michael E.
    Karsh, Lawrence Ivan
    Kibel, Adam S.
    Lane, Brian R.
    Lotan, Yair
    Lowrance, William Thomas
    Maroni, Paul
    Perrapato, Scott David
    Trabulsi, Edouard John
    Waterhouse, Robert J.
    Davicioni, Elai
    Lin, Daniel W.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Dose down-titration of biological disease-modifying antirheumatic drugs in daily clinical practice: Shared decision-making and patient treatment preferences in Japanese patients with rheumatoid arthritis
    Komiya, Takaaki
    Takase-Minegishi, Kaoru
    Sakurai, Natsuki
    Nagai, Hideto
    Hamada, Naoki
    Soejima, Yutaro
    Sugiyama, Yumiko
    Tsuchida, Naomi
    Kunishita, Yosuke
    Kishimoto, Daiga
    Kobayashi, Kouji
    Kamiyama, Reikou
    Yoshimi, Ryusuke
    Kirino, Yohei
    Ohno, Shigeru
    Nakajima, Hideaki
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (11) : 2009 - 2016
  • [35] Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT (vol 8, pg 876, 2018)
    Diefenbach, Michael A.
    Benedict, Catherine
    Miller, Suzanne M.
    Stanton, Annette L.
    Ropka, Mary E.
    Wen, Kuang-Yi
    Fleisher, Linda G.
    Mohamed, Nihal E.
    Hall, Simon J.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2021, 11 (06) : 1298 - 1298
  • [36] Decipher Test Impacts Decision Making Among Patients Considering Adjuvant and Salvage Treatment After Radical Prostatectomy: Interim Results From the Multicenter Prospective PRO-IMPACT Study
    Gore, John L.
    du Plessis, Marguerite G.
    Santiago-Jimenez, Maria K.
    Yousefi, Kasra K.
    Thompson, Darby K.
    Karsh, Lawrence P.
    Lane, Brian R.
    Franks, Michael T.
    Chen, David S.
    Bandyk, Mark P.
    Bianco, Fernando J.
    Brown, Gordon T.
    Clark, William R.
    Kibel, Adam S.
    Kim, Hyung A.
    Lowrance, William M.
    Manoharan, Murugesan T.
    Maroni, Paul U.
    Perrapato, Scott, V
    Sieber, Paul R.
    Trabulsi, Edouard J.
    Waterhouse, Robert C.
    Davicioni, Elai T.
    Lotan, Yair A.
    Lin, Daniel W.
    CANCER, 2017, 123 (15) : 2850 - 2859
  • [37] A Genomic Classifier Impacts Adjuvant Treatment Decision Making Among Patients With High-Risk Pathology at Radical Prostatectomy: Results From the Multicenter Prospective PRO-IMPACT Study
    Perrapato, S. D.
    Gore, J.
    du Plessis, M.
    Santiago-Jimenez, M.
    Yousefi, K.
    Thompson, D.
    Chen, D.
    Clark, W.
    Franks, M.
    Karsh, L.
    Kibel, A.
    Kim, H.
    Lane, B.
    Lotan, Y.
    Lowrance, W.
    Maroni, P.
    Trabulsi, E.
    Waterhouse, R.
    Davicioni, E.
    Lin, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S104 - S104
  • [38] Patient attributes considered for decision-making with regard to adjuvant chemotherapy in early stage HR+, HER2-breast cancer patients: Results of the Multidisciplinary Application of Genomics in Clinical Practice (MAGIC) survey
    Aapro, M.
    De Laurentiis, M.
    Mamounas, E.
    Martin, M.
    Rea, D.
    Rouzier, R.
    Smit, V.
    Thomssen, C.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S44 - S45
  • [39] Current treatment and decision-making factors leading to fusion vs decompression for one-level degenerative spondylolisthesis: survey results from members of the Lumbar Spine Research Society and Society of Minimally Invasive Spine Surgery
    Morse, Kyle W.
    Steinhaus, Michael
    Bovonratwet, Patawut
    Kazarian, Gregory
    Gang, Catherine Himo
    Vaishnav, Avani S.
    Lafage, Virginie
    Lafage, Renaud
    Iyer, Sravisht
    Qureshi, Sheeraz
    SPINE JOURNAL, 2022, 22 (11): : 1778 - 1787
  • [40] DID DECISION-MAKING MODELS FROM NATIONAL GUIDELINES CHANGE 1ST LINE TREATMENT STRATEGY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)? THE RESULTS OF LARGE POPULATION BASED SURVEY IN GERMANY 2009
    Kellermann, L.
    Hofheinz, R. D.
    Arnold, D.
    VALUE IN HEALTH, 2011, 14 (07) : A468 - A469
12345